Pharma & Healthcare

Total Market Cap 287.2B
P/E (Weighted)Price to Earnings ratio. 22.56 Medyan: 18.91
P/B (Weighted)Price to Book ratio. 4.98 Medyan: 2.23
P/E (Arithmetic)Simple average P/E. 26.95
Avg Lothien ScoreFinancial health score (0-100). 54
Avg DamodaranDamodaran scoring model. 34
Avg PotentialExpected upside potential %. -11.5%
Avg Dalio ScoreDalio debt cycle score. 67
Distributions
Lothien Distribution
0–25
0
25–40
0
40–55
2
55–70
3
70–100
0
Damodaran Distribution
0–25
0
25–40
4
40–55
1
55–70
0
70–100
0
Upside Potential
-100% – -20%
2
-20% – +0%
2
+0% – +20%
1
+20% – +50%
0
+50%+
0
Stocks in Sector
Stock PriceCurrent trading price. Market CapTotal market capitalization. FKPrice to Earnings ratio. PD/DDPrice to Book ratio. EV/EBITDAEnterprise Value / EBITDA. ROICReturn on Invested Capital. WACCWeighted Average Cost of Capital (WACC). PUSLAFinancial health score (0-100). DamodaranValuation score. Intrinsic ValueFair value via DCF model. Potential %Expected upside potential %. Dalio RiskDalio Debt Cycle Score Debt/EquityDebt to Equity ratio.
HIK
1,664.00 3.4B 12.83 1.81 8.15 15.3% 13.0% 66 34 2,003.96 +14.7% 64 0.61
SN
1,068.00 8.9B 18.91 2.23 9.52 10.2% 13.1% 61 31 990.47 -5.2% 70 0.63
GSK
1,916.00 76.8B 13.43 4.75 8.44 25.8% 10.4% 58 46 1,784.17 -4.6% 58 1.10
AZN
12,476.00 193.5B 25.30 5.32 14.42 17.3% 11.3% 46 32 7,290.97 -31.2% 69 0.61
CRDA
3,282.00 4.6B 73.89 2.09 19.93 8.9% 14.0% 41 25 1,859.04 -31.2% 72 0.32

The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.

A
AirSelim
Online
A
Hello! I am AirSelim, your Lothien finance assistant.

I can answer questions about market data, news, technical analysis, portfolio analysis and more.

I cover 26 exchanges (BIST, US, LSE, Xetra, Tadawul, KASE and others) — plus crypto.